brynovin

Generic: sitagliptin hydrochloride oral

Labeler: azurity pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name brynovin
Generic Name sitagliptin hydrochloride oral
Labeler azurity pharmaceuticals, inc.
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

sitagliptin 25 mg/mL

Manufacturer
Azurity Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 24338-017
Product ID 24338-017_9468a2f3-3ebe-40bd-a3b4-d78d9eb47e04
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA219122
Listing Expiration 2026-12-31
Marketing Start 2025-04-01

Pharmacologic Class

Established (EPC)
dipeptidyl peptidase 4 inhibitor [epc]
Mechanism of Action
dipeptidyl peptidase 4 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 24338017
Hyphenated Format 24338-017

Supplemental Identifiers

RxCUI
2716485 2716491
UPC
0371225120010
UNII
QFP0P1DV7Z
NUI
N0000175913 N0000175912

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name brynovin (source: ndc)
Generic Name sitagliptin hydrochloride oral (source: ndc)
Application Number NDA219122 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (24338-017-01) / 120 mL in 1 BOTTLE
source: ndc

Packages (1)

24338-017-01 1 BOTTLE in 1 CARTON (24338-017-01) / 120 mL in 1 BOTTLE

Ingredients (1)

sitagliptin (25 mg/mL)

Linked Drug Pages (1)

BRYNOVIN ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "9468a2f3-3ebe-40bd-a3b4-d78d9eb47e04", "openfda": {"nui": ["N0000175913", "N0000175912"], "upc": ["0371225120010"], "unii": ["QFP0P1DV7Z"], "rxcui": ["2716485", "2716491"], "spl_set_id": ["9468a2f3-3ebe-40bd-a3b4-d78d9eb47e04"], "pharm_class_epc": ["Dipeptidyl Peptidase 4 Inhibitor [EPC]"], "pharm_class_moa": ["Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "manufacturer_name": ["Azurity Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (24338-017-01)  / 120 mL in 1 BOTTLE", "package_ndc": "24338-017-01", "marketing_start_date": "20250401"}], "brand_name": "BRYNOVIN", "product_id": "24338-017_9468a2f3-3ebe-40bd-a3b4-d78d9eb47e04", "dosage_form": "SOLUTION", "pharm_class": ["Dipeptidyl Peptidase 4 Inhibitor [EPC]", "Dipeptidyl Peptidase 4 Inhibitors [MoA]"], "product_ndc": "24338-017", "generic_name": "Sitagliptin Hydrochloride Oral", "labeler_name": "Azurity Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BRYNOVIN", "active_ingredients": [{"name": "SITAGLIPTIN", "strength": "25 mg/mL"}], "application_number": "NDA219122", "marketing_category": "NDA", "marketing_start_date": "20250401", "listing_expiration_date": "20261231"}